Other relevant information

PHARMA MAR, S.A.

• • 22/07/2020
  • 17:51
  • PHARMA MAR, S.A.
  • Share buy-back , stabilisation and treasury stock programmes
  • The company reports the transactions performed in the context of the Share Buy-back Program between 15 July and 21 July 2020.
  • Register number: 3544
• • 22/07/2020
  • 08:29
  • PHARMA MAR, S.A.
  • Other relevant information
  • The Company informs of the admission to trading as of today of the new shares in the Stock Exchanges after the execution of the agreement of capital reduction and consolidation and exchange of shares (contra-split)
  • Register number: 3518
  • • Related to communication no. 3401 dated 14/07/2020 (17:40)
• • 15/07/2020
  • 17:38
  • PHARMA MAR, S.A.
  • Share buy-back , stabilisation and treasury stock programmes
  • The company reports the transactions performed in the context of the Share Buy-back Program between 8 July and 14 July 2020.
  • Register number: 3411
• • 14/07/2020
  • 17:40
  • PHARMA MAR, S.A.
  • Other relevant information
  • Registration within the Madrid Mercantile Registry of the resolution to reduce capital and consolidation and exchange of shares (contra-split)
  • Register number: 3401
• • 08/07/2020
  • 17:42
  • PHARMA MAR, S.A.
  • Share buy-back , stabilisation and treasury stock programmes
  • The company reports the transactions performed in the context of the Share Buy-back Program between 1 July and 7 July 2020.
  • Register number: 3313
• • 02/07/2020
  • 09:30
  • PHARMA MAR, S.A.
  • On business and financial situation
  • The Company announces that its partner in South Korea, Boryung Pharmaceutical, has presented the results of in vitro studies of plitidepsin (Aplidin®) in SARS-CoV-2.
  • Register number: 3138
• • 01/07/2020
  • 17:56
  • PHARMA MAR, S.A.
  • Share buy-back , stabilisation and treasury stock programmes
  • The company reports the transactions performed in the context of the Share Buy-back Program between 24 June and 30 June 2020.
  • Register number: 3125
• • 24/06/2020
  • 17:58
  • PHARMA MAR, S.A.
  • Share buy-back , stabilisation and treasury stock programmes
  • The company reports the transactions performed in the context of the Share Buy-back Program between 17 June and 23 June 2020.
  • Register number: 2979
• • 18/06/2020
  • 14:32
  • PHARMA MAR, S.A.
  • Other relevant information
  • The Board of Directors agrees to execute the reverse share split agreed by the General Shareholders’ Meeting.
  • Register number: 2862
• • 18/06/2020
  • 13:51
  • PHARMA MAR, S.A.
  • Other relevant information
  • The Company informs about the dividend payment
  • Register number: 2858